RS57900B1 - Postupci i reagensi za održavanje u životu ćelija kancera u hirurški uklonjenom tkivu - Google Patents

Postupci i reagensi za održavanje u životu ćelija kancera u hirurški uklonjenom tkivu

Info

Publication number
RS57900B1
RS57900B1 RS20180976A RSP20180976A RS57900B1 RS 57900 B1 RS57900 B1 RS 57900B1 RS 20180976 A RS20180976 A RS 20180976A RS P20180976 A RSP20180976 A RS P20180976A RS 57900 B1 RS57900 B1 RS 57900B1
Authority
RS
Serbia
Prior art keywords
alkyl
groups
optionally
halo
group
Prior art date
Application number
RS20180976A
Other languages
English (en)
Serbian (sr)
Inventor
Tony K Baker
Original Assignee
Truckee Applied Genomics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truckee Applied Genomics Llc filed Critical Truckee Applied Genomics Llc
Publication of RS57900B1 publication Critical patent/RS57900B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
RS20180976A 2013-03-15 2014-03-14 Postupci i reagensi za održavanje u životu ćelija kancera u hirurški uklonjenom tkivu RS57900B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798627P 2013-03-15 2013-03-15
EP14763797.9A EP2970878B1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue
PCT/US2014/029198 WO2014144682A1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue

Publications (1)

Publication Number Publication Date
RS57900B1 true RS57900B1 (sr) 2019-01-31

Family

ID=51528685

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20180976A RS57900B1 (sr) 2013-03-15 2014-03-14 Postupci i reagensi za održavanje u životu ćelija kancera u hirurški uklonjenom tkivu

Country Status (17)

Country Link
US (5) US9113623B2 (enExample)
EP (2) EP3581643A1 (enExample)
JP (1) JP6465857B2 (enExample)
CN (2) CN105121629B (enExample)
CA (1) CA2941929C (enExample)
CY (1) CY1120801T1 (enExample)
DK (1) DK2970878T3 (enExample)
ES (1) ES2684582T3 (enExample)
HR (1) HRP20181352T1 (enExample)
HU (1) HUE039933T2 (enExample)
LT (1) LT2970878T (enExample)
PL (1) PL2970878T3 (enExample)
PT (1) PT2970878T (enExample)
RS (1) RS57900B1 (enExample)
SI (1) SI2970878T1 (enExample)
SM (1) SMT201800457T1 (enExample)
WO (1) WO2014144682A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂
US10053676B2 (en) 2014-11-25 2018-08-21 Bio-Rad Laboratories, Inc. Arginine improves polymerase storage stability
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
WO2021055170A1 (en) * 2019-09-17 2021-03-25 Longhorn Vaccines And Diagnostics, Llc Multipurpose compositions for collecting and transporting biological material
WO2022010916A1 (en) * 2020-07-07 2022-01-13 Truckee Applied Genomics, Llc Cell preservation reagents and methods of use
CN117063915B (zh) * 2023-08-17 2026-02-24 镜像绮点(上海)细胞技术有限公司 原代肿瘤细胞冻存液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409826A (en) * 1993-06-08 1995-04-25 Coulter Corporation Preserved, non-infectious control cells prepared by the modulation or modification of normal cells
JP2000509018A (ja) * 1996-03-26 2000-07-18 イーライ・リリー・アンド・カンパニー 肥満タンパク質製剤
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
JP2001526051A (ja) 1997-12-10 2001-12-18 シエラ ダイアグノスティクス,インク. 体液中のdnaを保存するための方法及び試薬
US20080064108A1 (en) 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
CN1230524C (zh) * 2000-12-04 2005-12-07 株式会社淋巴技术 细胞保存液和使用该保存液的细胞保存方法
KR20020066778A (ko) 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
WO2008111981A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation of macromolecules
AU2003300899A1 (en) * 2002-12-12 2004-06-30 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
US8793895B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
CN101617045A (zh) 2006-09-12 2009-12-30 谢拉分子公司 使用离液剂的缓冲溶液去除核酸的分子分析干扰物
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
EP2086622A2 (en) 2006-10-27 2009-08-12 Sierra Molecular Corporation Penetratable septum cap
WO2008071384A1 (en) 2006-12-13 2008-06-19 Roche Diagnostics Gmbh Use of tde for the isolation of nucleic acids
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
AU2008321382A1 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of uterine cancer and ovarian cancer with a PARP inhibitor alone or in combination with anti-tumor agents
WO2010003037A2 (en) * 2008-07-03 2010-01-07 Sierra Molecular Corporation Compositions, systems, and methods for stabilization of a cell and/or macromolecule
WO2010028156A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
US9133343B2 (en) * 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂

Also Published As

Publication number Publication date
WO2014144682A8 (en) 2015-08-13
HUE039933T2 (hu) 2019-02-28
US20150327539A1 (en) 2015-11-19
ES2684582T3 (es) 2018-10-03
JP6465857B2 (ja) 2019-02-06
CA2941929C (en) 2021-02-23
US9949474B2 (en) 2018-04-24
SI2970878T1 (sl) 2019-02-28
HK1220481A1 (en) 2017-05-05
SMT201800457T1 (it) 2018-11-09
HRP20181352T1 (hr) 2018-12-14
WO2014144682A4 (en) 2014-12-24
US10772318B2 (en) 2020-09-15
US20160235055A1 (en) 2016-08-18
US9113623B2 (en) 2015-08-25
EP3581643A1 (en) 2019-12-18
US20150230454A1 (en) 2015-08-20
US9445586B2 (en) 2016-09-20
EP2970878B1 (en) 2018-05-23
DK2970878T3 (en) 2018-09-03
LT2970878T (lt) 2018-11-12
EP2970878A1 (en) 2016-01-20
US20170215410A1 (en) 2017-08-03
CN105121629B (zh) 2020-12-18
CN105121629A (zh) 2015-12-02
PL2970878T3 (pl) 2019-01-31
PT2970878T (pt) 2018-10-09
CA2941929A1 (en) 2014-09-18
US9565852B2 (en) 2017-02-14
CN112806352A (zh) 2021-05-18
EP2970878A4 (en) 2016-08-03
US20140272921A1 (en) 2014-09-18
JP2016512693A (ja) 2016-05-09
WO2014144682A1 (en) 2014-09-18
CY1120801T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
AU2023201159B2 (en) Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof
EP3077399B1 (en) Methods useful in the synthesis of halichondrin b analogs
CN114787139B (zh) 用于制备mcl1抑制剂的方法和中间体
EP3172218B1 (en) Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
PT1506214E (pt) Derivados de cetólido 6-11 bicíclicos
HK1207384A1 (en) Process for the preparation of 2-deoxy-2-fluoro-2-methyl-d-ribofuranosyl nucleoside compounds
AU2008335668C1 (en) 6, 11-bridged biaryl macrolides
SG191841A1 (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
Rosen et al. Aromatic dienoyl tetramic acids. Novel antibacterial agents with activity against anaerobes and staphylococci
Ivanova et al. Non-natural nucleosides bearing 4-aryldiazenylpyrazole aglycone
KR20090018892A (ko) 안정화된 2-요오도옥시벤조산(sibx)에 의한 목시덱틴 제조시 유용한 향상된 안전성을 갖는 개선된 산화 방법
IT202100008429A1 (it) Processo per la preparazione di cortexolone 17α-propionato e sua nuova forma cristallina idrata
CA2321336C (en) Synthesis of carbamate ketolide antibiotics
KR20070103012A (ko) 신규 피리미딘 뉴클레오시드화합물 또는 그의 염
US6403776B1 (en) Synthesis of carbamate ketolide antibiotics
AU756816B2 (en) Glycosidation of 4,5-epoxymorphinan-6-ols
MXPA00009540A (en) Synthesis of carbamate ketolide antibiotics
JP7641918B2 (ja) 炭素環ヌクレオシド類似体
Strohmeier et al. Synthesis of 8, 1'-Etheno and 8, 2'-Ethano Bridged Guanosine Derivatives Using Radical Cyclization
JP2025539267A (ja) ヌクレオシド誘導体nuc-3373の合成
Meier et al. Stereoselective synthesis of 3-methyl-cycloSal-nucleotides
HK1232546A1 (en) Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
HK1141025B (en) 6, 11-bridged biaryl macrolides
HK1141025A (en) 6, 11-bridged biaryl macrolides